KERAFOAM 42 - urea aerosol, foam 
Onset Therapeutics, LLC

----------


Kerafoam 42
For softening, smoothing and removing rough scaling hyperkeratotic skin

DESCRIPTION:

KERAFOAM® 42 Emollient Foam is a keratolytic emollient foam which is a tissue softener for skin and/or nails. Each gram of KERAFOAM 42 Emollient Foam contains 42% urea USP, ceteareth-10 phosphate, cetearyl alcohol NF, dicetyl phosphate, dl-alpha tocopheryl acetate USP, edetate disodium dihydrate USP, methylparaben NF, propylene glycol USP, propylparaben NF, purified water USP, sodium phosphate monobasic USP. Also contains: Propellant HFA-134a (1,1,1,2- tetrafluoroethane).
Urea USP is a diamide of carbonic acid with the following chemical structure:

K42 Chemical Structure


CLINICAL PHARMACOLOGY

Urea gently lyses/dissolves the intercellular matrix of surface skin cells loosening and allowing a shedding of rough, thickened and scaly hyperkeratotic skin. Urea also moisturizes and softens skin.

INDICATIONS

For softening, smoothing and removing rough scaling hyperkeratotic skin in conditions such as xerosis, ichthyosis, skin cracks and fissures, dermatitis, eczema, psoriasis, keratoses and calluses.

CONTRAINDICATIONS

Known hypersensitivity to any of the listed ingredients. Discontinue use if hypersensitivity is observed.

WARNINGS

FOR EXTERNAL USE ONLY. Avoid contact with eyes, lips or mucous membranes. Keep out of the reach of children. Contents under pressure. Do not puncture or incinerate container. Do not expose to temperatures above 120ºF (49ºC).

PRECAUTIONS

Information for patients:

This medication is to be used as directed by a physician and should not be used to treat any condition other than that for which it was prescribed. If redness or irritation occurs, discontinue use.

Pregnancy

Pregnancy Category C. Animal reproduction studies have not been conducted with KERAFOAM 42 Emollient Foam. It is not known whether KERAFOAM 42 Emollient Foam can cause fetal harm when administered to a  pregnant woman or can affect reproduction capacity. KERAFOAM 42 Emollient Foam should be given to a pregnant woman only if clearly needed.

Nursing Mothers

It is not known whether or not this drug is secreted in human milk. Because many drugs are secreted in human milk, caution should be exercised when KERAFOAM 42 Emollient Foam is administered to a nursing woman.

ADVERSE REACTIONS

Transient stinging, burning, itching or irritation may occur and normally disappear on discontinuing the medication.

DOSAGE AND ADMINISTRATION


Shake Vigorously, Tap Bottom of Can, and Prime Before Initial Use. Shake Vigorously and Tap Before Each Use.
To Prime: After shaking, gently tap bottom of can onto palm of other hand or a solid surface at least 3 times. Hold the can upright, direct away from the patient, and firmly depress the actuator for 1 to 3 seconds or until foam begins to dispense. (If foam does not dispense within 3 seconds: re-shake can, gently tap bottom of can onto a solid surface at least 3 times, and depress the actuator again until foam begins to dispense.)
Before Each Use: Shake vigorously and gently tap bottom of can onto palm of other hand or a solid surface at least 3 times.
During Use: Holding can upright, dispense KERAFOAM 42 into palm of hand and apply to affected area twice per day, or as directed by a physician. Rub in until completely absorbed. Wipe off any excess foam from actuator after use.

HOW SUPPLIED

KERAFOAM 42 Emollient Foam is supplied in a 60 g (NDC# 16781-181-60) aluminum can.

Store at room temperature: 59º - 77ºF (15º - 25ºC). Protect from freezing. Store upright.

Patent Pending

P/N 2614 Rev. 0

Manufactured For:

Onset Logo

Onset Therapeutics
Cumberland, RI 02864

(888) 713-8154
www.onsettx.com

PACKAGE LABEL - PRINCIPAL DISPLAY PANEL - Kerafoam42-Outer Box - 5g

Outer Box - 5g


PACKAGE LABEL - PRINCIPAL DISPLAY PANEL - Kerafoam42-Inner Label - 5g

Inner Label - 5g


PACKAGE LABEL - PRINCIPAL DISPLAY PANEL - Kerafoam42-Outer Box - 10g

Outer Box - 10g


PACKAGE LABEL - PRINCIPAL DISPLAY PANEL - Kerafoam42-Inner Label - 10g

Inner Label - 10g


PACKAGE LABEL - PRINCIPAL DISPLAY PANEL - Kerafoam42-Outer Box - 60g

Outer Box - 60g


PACKAGE LABEL - PRINCIPAL DISPLAY PANEL - Kerafoam42-Inner Label - 60g

Inner Label - 60g


PACKAGE LABEL - PRINCIPAL DISPLAY PANEL - Kerafoam42-Outer Box - 100g

Outer Box - 100g


PACKAGE LABEL - PRINCIPAL DISPLAY PANEL - Kerafoam42-Inner Label - 100g

Inner Label - 100g


KERAFOAM 42 
urea   aerosol, foam
Product Information
Product TypeHUMAN PRESCRIPTION DRUGNDC Product Code (Source)16781-181
Route of AdministrationTOPICALDEA Schedule    
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
UREA (UREA) UREA43.26 g  in 100 g
Inactive Ingredients
Ingredient NameStrength
WATER42.59 g  in 100 g
PROPYLENE GLYCOL5 g  in 100 g
SODIUM PHOSPHATE, MONOBASIC3.45 g  in 100 g
CETOSTEARYL ALCOHOL2 g  in 100 g
METHYLPARABEN0.3 g  in 100 g
ALPHA-TOCOPHEROL ACETATE0.2 g  in 100 g
EDETATE DISODIUM0.1 g  in 100 g
PROPYLPARABEN0.1 g  in 100 g
Product Characteristics
Color    Score    
ShapeSize
FlavorImprint Code
Contains    
Packaging
#NDCPackage DescriptionMultilevel Packaging
116781-181-061 CAN In 1 BOXcontains a CAN
15 g In 1 CANThis package is contained within the BOX (16781-181-06)
216781-181-111 CAN In 1 BOXcontains a CAN
210 g In 1 CANThis package is contained within the BOX (16781-181-11)
316781-181-601 CAN In 1 BOXcontains a CAN
360 g In 1 CANThis package is contained within the BOX (16781-181-60)
416781-181-961 CAN In 1 BOXcontains a CAN
4100 g In 1 CANThis package is contained within the BOX (16781-181-96)

Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
unapproved other04/01/2009

Labeler - Onset Therapeutics, LLC (793223707)
Registrant - Collegium Pharmaceutical, Inc. (032531241)
Establishment
NameAddressID/FEIOperations
Onset Therapeutics, LLC793223707RELABEL
Establishment
NameAddressID/FEIOperations
Collegium Pharmaceutical, Inc.032531241MANUFACTURE
Revised: 07/2009Onset Therapeutics, LLC